Drug Profile
Clindamycin/tretinoin - Dr. Reddys Laboratories
Alternative Names: Tretinoin/clindamycin- Dr. Reddys LaboratoriesLatest Information Update: 30 Mar 2021
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Antiacnes; Antibacterials; Keratolytics; Lincosamides; Retinoids; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne vulgaris
Most Recent Events
- 30 Mar 2021 No development reported - Phase-III for Acne vulgaris in India (Topical)
- 30 Jan 2019 Chemical structure information added
- 09 Mar 2018 Dr. Reddys Laboratories completes a phase III trial in Acne vulgaris in India (Topical) (CTRI2014-08-004830), before March 2018